Recognition of tumor-specific gene products in cancer
US6686165B2 · kind B2 · utility
6Cited by
4References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 29, 2000 |
| Grant date | Feb 3, 2004 |
| Priority date | — |
| Expiry date | Dec 29, 2020 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/82
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to the field of cancer diagnosis and the application of diagnostic techniques in pathology and hematology. Specifically, the invention relates to flow cytometric techniques for the detection of chromosomal aberrations and the detection of tumor specific gene products exclusively expressed by tumor cells containing said chromosomal aberrations. The invention provides a method to detect chromosomal aberrations in a biological sample via the exclusive detection of tumor-specific gene-product using at least two different probes directed against the gene-product.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.